You are currently visiting our International webshop, visitors from the UK, ES, NL, BE, DE and FR. Please make sure you choose the correct webshop of your country, scroll down the page to choose the correct store. If your country is not available in the dropdown below you can shop at the international website. Thank you!

Antirobe 25 mg 80 caps

Nr.
180311
Brand:
Pfizer
Batch:
B769204
Expiry date:
30-Sep-2027
Registration number:
FR/V/2992805 3/1989 - BE: BE-V155102

Is the registration number of your country not listed? Then this product falls within the cascade control system.

Capsules for dogs and cats containing clindamycin.

More info

Disclaimer: Product in the photo may differ from the actual product.

Antirobe 25mg 80caps

Key benefits

  • Concentrates in leukocytes, quickly reaching the infection site to treat intracellular pathogens.
  • Activity against susceptible strains of aerobic and anaerobic bacteria.
  • Maintains full antimicrobial activity in purulent environments.
  • Penetrates biofilms found in both dental and bone infections.
  • No reconstitution or refrigeration needed.
  • Convenient once-a-day dosing for cats.

Antirobe is indicated for:
Dogs
The treatment of skin infections (wounds and abscesses) due to coagulase positive staphylococci (Staphylococcus aureus or Staphylococcus intermedius). Deep wounds and abscesses due to Bacteroides fragilis, Prevotella melaninogenicus, Fusobacterium necrophorum and Clostridium perfringens.
Dental infections due to Staphylococcus aureus, Bacteroides fragilis, Prevotella melaninogenicus, Fusobacterium necrophorum and Clostridium perfringens.
Osteomyelitis due to Staphylococcus aureus, Bacteroides fragilis, Prevotella melaninogenicus, Fusobacterium necrophorum and Clostridium perfringens.

Cats
The treatment of skin infections (wounds and abscesses) due to Staphylococcus aureus, Staphylococcus intermedius, Streptococcus spp. Deep wounds and infections due to Clostridium perfringens and Bacteroides fragilis.
Dental infections due to Staphylococcus aureus, Staphylococcus intermedius, Streptococcus spp., Clostridium perfringens and Bacteroides fragilis.

 

© 2024 Grovet B.V. All rights reserved.